RTX business Raytheon will manufacture additional AIM-9X Sidewinder missiles under a $1.1 billion modification of a previously awarded contract. The modification exercises options of the previous ...

Raytheon, an RTX business, will perform the work in Andover, Massachusetts, with completion expected by March 31, 2030.

The Army has awarded Raytheon a $1.025 billion contract modification to support production of the Lower Tier Air and Missile Defense Sensor.

General Dynamics Electric Boat (GDEB) has received a $1.85bn contract modification for the procurement of long lead time materials and to initiate preliminary construction activities for the US Navy ...

Raytheon, a subsidiary of Arlington County-based Fortune 500 aerospace and defense contractor RTX, has been awarded a $646 million contract modification to continue producing the AN/SPY-6(V) family of ...

Investing.com -- L3Harris Technologies Inc. has been awarded a $62.7 million modification to an existing contract by the U.S. Department of War.

The Defense Department issued Optum a $172 million contract modification for its indefinite-delivery bridge contract, according to a Dec. 13 news release. The award extends Optum’s contract through ...

Emergent BioSolutions receives a $62.4 million contract modification to supply Botulism Antitoxin for U.S. public health protection. Emergent BioSolutions Inc. announced the award of a $62.4 million ...

REDSTONE ARSENAL, Ala. (WHNT) — Alabama agencies for the week of August 11-15 are set to be working locations or the contracting activities for 12 Department of Defense contracts. Each day of the work ...

Following the delivery of the last of its new F-15SA advanced fighter aircraft to the Royal Saudi Air Force on December 14 2020, as part of a $29bn foreign military sales (FMS) agreement signed in ...

GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research ...

Emergent BioSolutions Inc. announced a contract modification with the U.S. Department of Health and Human Services to provide additional doses of its smallpox treatment, CNJ-016® (Vaccinia Immune ...